Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vet Clin Pathol ; 51(3): 356-375, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-35608195

RESUMO

BACKGROUND: Clinical pathology and body weight information for the cynomolgus monkey in the literature is primarily derived from a small number of animals with limited age ranges, varying geographic origins, and mixed genders. OBJECTIVES: This study aimed to summarize the age- and sex-related changes in clinical pathology analytes and body weights in cynomolgus monkeys of Mauritian origin. METHODS: Pre-study age and body weight data were reviewed in 1819 animals, and pre-study hematologic, coagulation, and serum biochemical analytes were reviewed in 1664 animals. RESULTS: Body weights were statistically higher (P < 0.01) in males than females in all age groups (2-10 years). These measurements became prominent after 4 years of age and peaked at 7 to 8 years of age in both sexes. Sex-related differences were noted in reticulocyte (RETIC) counts, creatinine, cholesterol, and triglyceride concentrations, and alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) activities. Age-related differences were noted in RETIC and lymphocyte counts, creatinine, triglyceride, phosphorus, and globulin concentrations, and ALP and GGT activities. The youngest (2 to <3 year) age group had the fewest number of clinical pathologic analyte differences including ALP and GGT activity differences which occurred in all age groups from 2 to 10 years; they also had age-related lower globulin concentrations. There were no age- or sex-related differences in coagulation measurands. CONCLUSIONS: Sexual dimorphism in body weight was apparent for all ages from 2 to 10 years of age. The only difference in clinical pathology analytes unique to the 2 to <3 years of age group were age-related lower globulin levels.


Assuntos
Globulinas , Patologia Clínica , Animais , Peso Corporal , Creatinina , Feminino , Macaca fascicularis , Masculino , Maurício , Triglicerídeos
2.
Int J Toxicol ; 37(3): 223-233, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29554821

RESUMO

Glomerulopathy and body weight gain were noted after chronic oral administration of a novel nonsteroidal dissociated agonist of the glucocorticoid receptor compound, fosdagrocorat, to beagle dogs fed an ad libitum diet. To further investigate the role of diet and treatment with either fosdagrocorat or the glucocorticoid comparator, prednisone, on renal safety, a 13-week investigative study was conducted in beagle dogs. Renal histopathology, clinical chemistry, urinalysis, glomerular filtration rate (GFR), body weight, heart rate, blood pressure (BP), and hematology were investigated in restricted- and ad libitum-fed dogs administered prednisone (2.2 mg/kg/d), fosdagrocorat (5 mg/kg/d), or vehicle for 13 weeks. Glomerulopathy was primarily observed in fosdagrocorat- and prednisone-treated ad libitum but not in feed-restricted or ad libitum vehicle-treated dogs. Kidneys in dogs from the prednisone-treated ad libitum had the greatest incidence and severity of tubular degenerative changes. Increased urine volume and decreased urine-specific gravity were present in prednisone- and fosdagrocorat-treated dogs, regardless of diet. These changes were not associated with consistent changes in GFR. Fosdagrocorat or prednisone treatment ad libitum dogs had the greatest increase in body weight gain. Sporadic changes in systolic and diastolic BP were noted in fosdagrocorat- and prednisone-treated groups. Significant reductions in serum cortisol and absolute eosinophils were noted in both ad libitum- and restriction-fed prednisone- and fosdagrocorat-treated dogs. In conclusion, prednisone-treated dogs fed ad libitum had greater glucocorticoid-induced renal effects than those dosed with fosdagrocorat.


Assuntos
Rim/efeitos dos fármacos , Organofosfatos/farmacologia , Fenantrenos/farmacologia , Prednisona/farmacologia , Receptores de Glucocorticoides/agonistas , Animais , Pressão Sanguínea/efeitos dos fármacos , Peso Corporal/efeitos dos fármacos , Cães , Ingestão de Alimentos/efeitos dos fármacos , Feminino , Privação de Alimentos , Taxa de Filtração Glomerular/efeitos dos fármacos , Frequência Cardíaca/efeitos dos fármacos , Rim/patologia , Organofosfatos/administração & dosagem , Organofosfatos/efeitos adversos , Fenantrenos/administração & dosagem , Fenantrenos/efeitos adversos , Prednisona/efeitos adversos , Receptores de Glucocorticoides/efeitos dos fármacos
3.
Comp Med ; 66(6): 480-488, 2016 12 01.
Artigo em Inglês | MEDLINE | ID: mdl-28304252

RESUMO

Testicular volume is one of several parameters that have been used in preclinical toxicology to facilitate the identification of sexually mature male cynomolgus macaques when semen evaluation is unavailable. Furthermore, testicular volume provides additional information to pathologists to aid in the interpretation of microscopic findings. Orchidometry has been proposed as a useful tool for assessing testicular volume. To assess its utility for this purpose, we used orchidometry to measure testicular volume in untreated control male cynomolgus macaques during preclinical toxicology studies. Additional parameters including age, body weight, testicular weight, serum testosterone, and testicular histology were also evaluated. Serum inhibin B and the diameter of histologic testicular sections were assessed to determine whether they might provide any additional corroborative evidence for differentiating stages of sexual maturity in males. Orchidometry was easy to use in sedated or awake macaques and, in combination with testicular histology, enabled the establishment of cut-off values by which sexually mature male cynomolgus macaques can be identified with a high degree of confidence. The relative utility of the parameters examined for discriminating sexually mature and immature males was testicular volume ≥ serum testosterone > body weight > age; for differentiation of sexually mature and peripubertal males the order was testicular volume ≥ body weight > serum testosterone > age. Testicular weight and the diameter of histologic testicular sections provided corroborative information for discriminating stages of sexual maturity. Serum inhibin B was of little value in helping to differentiate the different stages of sexual maturation evaluated in this study.


Assuntos
Macaca fascicularis/crescimento & desenvolvimento , Maturidade Sexual/fisiologia , Testículo/patologia , Animais , Biomarcadores/sangue , Peso Corporal , Inibinas/sangue , Macaca fascicularis/anatomia & histologia , Masculino , Testosterona/sangue
4.
Toxicol Pathol ; 42(4): 784-91, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24670818

RESUMO

Several classes of drugs have been shown to cause drug-induced vascular injury (DIVI) in preclinical toxicity studies. Measurement of blood flow and vessel diameter in numerous vessels and across various tissues by ultrasound imaging has the potential to be a noninvasive translatable biomarker of DIVI. Our objective was to demonstrate the utility of high-frequency ultrasound imaging for measuring changes in vascular function by evaluating blood flow and vessel diameter in the superior mesenteric arteries (SMA) of rats treated with compounds that are known to cause DIVI and are known vasodilators in rat: fenoldopam, CI-1044, and SK&F 95654. Blood flow, vessel diameter, and other parameters were measured in the SMA at 4, 8, and 24 hr after dosing. Mild to moderate perivascular accumulations of mononuclear cells, neutrophils in tunica adventitia, and superficial tunica media as well as multifocal hemorrhage and necrosis in the tunica media were found in animals 24 hr after treatment with fenoldopam and SK&F 95654. Each compound caused marked increases in blood flow and shear stress as early as 4 hr after dosing. These results suggest that ultrasound imaging may constitute a functional correlate for the microscopic finding of DIVI in the rat.


Assuntos
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Ultrassonografia/métodos , Lesões do Sistema Vascular/induzido quimicamente , Lesões do Sistema Vascular/patologia , Animais , Azepinas/efeitos adversos , Fenoldopam/efeitos adversos , Hemodinâmica , Masculino , Artérias Mesentéricas/diagnóstico por imagem , Artérias Mesentéricas/efeitos dos fármacos , Niacinamida/efeitos adversos , Niacinamida/análogos & derivados , Piridazinas/efeitos adversos , Piridinas/efeitos adversos , Ratos , Ratos Sprague-Dawley , Lesões do Sistema Vascular/diagnóstico por imagem
5.
J Am Assoc Lab Anim Sci ; 52(5): 545-52, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24041209

RESUMO

Trypanosoma cruzi, the causative agent of Chagas disease, is endemic in south Texas due to the abundant vector and wild small mammalian reservoir populations. This situation predisposes nonhuman primate colonies exposed to outdoor housing to infection from ingestion or bite of triatomid insects. Using a T. cruzi-specific real-time PCR and Trypanosome spp.-specific ELISA, we revealed a prevalence rate of 8.5% in a colony of outdoor-housed cynomolgus macaques. By using a discriminating kinetoplastid minicircle PCR, we eliminated the possibility of mixed prevalence with nonpathogenic trypanosomes and showed the ELISA results were specific for T. cruzi. In this study, we found an inverse relationship between antibody titers and circulating parasite load. Also, 23% of T. cruzi IgG ELISA-positive macaques were negative by real-time PCR. Furthermore, in a subset of infected macaques, cardiac tissue was infiltrated by inflammatory mononuclear cells and contained T. cruzi genomic and kinetoplast DNA despite lacking microscopic evidence of discrete parasite stages. In addition, 19% of the infected macaques had titers for cardiac troponin I autoantibody, which could contribute to autoimmune myocarditis or interfere with circulating troponin I measurements. These findings indicate the possibility of T. cruzi to interfere with the assessment of cardiac safety signals in preclinical toxicology and safety pharmacology studies and the necessity for prestudy screening for T. cruzi in outdoor-housed nonhuman primates from endemic areas.


Assuntos
Anticorpos Antiprotozoários/sangue , Cardiomiopatia Chagásica , Doença de Chagas , Macaca fascicularis/parasitologia , Trypanosoma cruzi/imunologia , Animais , Autoanticorpos/sangue , Cardiomiopatia Chagásica/epidemiologia , Cardiomiopatia Chagásica/imunologia , Cardiomiopatia Chagásica/veterinária , Doença de Chagas/epidemiologia , Doença de Chagas/imunologia , Doença de Chagas/veterinária , DNA de Protozoário/análise , Ensaio de Imunoadsorção Enzimática , Abrigo para Animais , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Macaca fascicularis/imunologia , Reação em Cadeia da Polimerase , Reação em Cadeia da Polimerase em Tempo Real , Estudos Soroepidemiológicos , Troponina I/imunologia , Trypanosoma cruzi/genética , Trypanosoma cruzi/crescimento & desenvolvimento
6.
Environ Mol Mutagen ; 52(9): 748-55, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22052433

RESUMO

An international collaborative trial was established to systematically investigate the merits and limitations of a rat in vivo Pig-a gene mutation assay. The product of this gene is essential for anchoring CD59 to the plasma membrane, and mutations in this gene are identified by flow cytometric quantification of circulating erythrocytes without cell surface CD59 expression. Initial interlaboratory data from rats treated with several potent mutagens have been informative, but the time required for those flow cytometric analyses (∼20 min per sample) limited the number of cells that could be interrogated for the mutant phenotype. Thus, it was desirable to establish a new higher throughput scoring approach before expanding the trial to include weak mutagens or nongenotoxicants. An immunomagnetic column separation method that dramatically increases analysis rates was therefore developed (Dertinger et al. [2011]: Mutat Res 721:163-170). To evaluate this new method for use in the international collaborative trial, studies were conducted to determine the mutagenic response of male Sprague Dawley rats treated for 3 or 28 consecutive days with several doses of 1,3-propane sultone (1,3-PS). Pig-a mutant frequencies were measured over a period of several weeks and were supplemented with another indicator of genetic toxicity, peripheral blood micronucleated reticulocyte (MN-RET) counts. 1,3-PS was found to increase Pig-a mutation and MN-RET frequencies in both 3- and 28-day study designs. While the greatest induction of MN-RETs was observed in the 3-day study, the highest Pig-a responses were found with 28-days of treatment. Pig-a measurements were acquired in approximately one-third the time required in the original method, while the number of erythrocyte and reticulocyte equivalents analyzed per sample were increased by factors of 100 and 10, respectively. The data strongly support the value of using the immunomagnetic separation technique for enumerating Pig-a mutation frequencies. These results also demonstrate that the ongoing international trial will benefit from the inclusion of studies that are based on both acute and protracted repeat dosing schedules in conjunction with the acquisition of longitudinal data, at least until more data have been accumulated.


Assuntos
Eritrócitos/efeitos dos fármacos , Separação Imunomagnética/métodos , Proteínas de Membrana/genética , Micronúcleos com Defeito Cromossômico/induzido quimicamente , Testes de Mutagenicidade , Mutagênicos/toxicidade , Tiofenos/toxicidade , Animais , Antígenos CD59/genética , Calibragem , Interpretação Estatística de Dados , Relação Dose-Resposta a Droga , Determinação de Ponto Final , Eritrócitos/metabolismo , Eritrócitos/ultraestrutura , Citometria de Fluxo , Cooperação Internacional , Laboratórios/normas , Masculino , Testes para Micronúcleos/métodos , Testes para Micronúcleos/normas , Testes de Mutagenicidade/métodos , Testes de Mutagenicidade/normas , Ratos , Ratos Sprague-Dawley , Padrões de Referência , Reprodutibilidade dos Testes , Reticulócitos/efeitos dos fármacos , Reticulócitos/metabolismo , Reticulócitos/ultraestrutura , Medição de Risco , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...